Robert Hillman is a Principal Scientist at Abbott since June 2015, specializing in assay research and development. Prior to this role, Robert served as a Senior Scientist, contributing to the development of the Realtime SARS-CoV-2 EUA assay. Earlier experience includes a Research Scientist position at the Center for Innovation in Global Health Technologies at Northwestern University, where Robert led the development of a qPCR-based diagnostic assay for multi-drug resistant M. tuberculosis. Additional roles include Research Technician at the University of Chicago, focusing on CDC-classified pathogens, and Research Specialist at the University of Illinois at Chicago, where Robert contributed to research on the pathology of endometriosis. Robert holds a Bachelor of Science degree in Biochemistry and Molecular Biology from the University of Wisconsin-Madison.
This person is not in the org chart
This person is not in any teams
This person is not in any offices